<img src="https://secure.intelligence52.com/795232.png" style="display:none;">

Blog

Protocol Amendments in Clinical Trials: Requirements and Impact

By Clinical Data Management Team
September 25, 2026
Explore how protocol and mid-study amendments in clinical trials can change study conduct, data collection, and analysis.
Learn more

Multi-Omics in Clinical Research: Choosing an Integration Strategy

By Statistical Consultancy Team
September 24, 2026
See how clinical multi-omics data is integrated and analysed, where single-cell and spatial methods fit, and what can limit wider clinical use.
Learn more

Equivalence Trials: Design, Analysis & Interpretation

By Statistical Consultancy Team
September 17, 2026
See how equivalence trials are designed and analysed, including margins, confidence intervals, sample size, assay sensitivity and re-randomisation.
Learn more

Longitudinal Observational Data in Paediatric Disease Registries

By Statistical Consultancy Team
September 11, 2026
How longitudinal observational data from registries can inform growth, maturation and safety analyses, with key risks around bias and follow-up.
Learn more

Tipping Point Analysis in Clinical Trials

By Statistical Consultancy Team
September 9, 2026
Understand tipping point analysis in clinical trials, including MAR, MNAR, delta shifts, endpoint types, and key limitations.
Learn more

Clinical Trial Planning and Design: What to Plan Before Execution

By Statistical Consultancy Team
September 4, 2026
See how clinical trial planning and design connects the research question with population, endpoints, comparator choice, analysis and feasibility.
Learn more

What is a Clinical Development Plan (CDP) and What Should It Include?

By Statistical Consultancy Team
September 2, 2026
Understand how a clinical development plan supports cross-functional decisions, regulatory interactions, risk planning and trial delivery.
Learn more

Clinical Trial Trends Shaping Modern Drug Development

By Commercial Team
August 28, 2026
Explore clinical trial trends affecting the future of clinical trials, including DCTs, PROs, advanced therapies and outsourcing.
Learn more

The Analysis of Direct and Indirect Pathways in Observational Studies

By Statistical Consultancy Team
August 26, 2026
Understand direct vs indirect pathways in an AS observational study, including direct effect, indirect effect, binary mediators, and limitations.
Learn more

The Role of Data Monitoring Committees (DMC) in Clinical Trials

By Statistical Consultancy Team
August 21, 2026
A practical data monitoring committee overview covering DMC responsibilities, confidentiality, interim analysis and independent statistical support.
Learn more

Group Sequential Designs in Clinical Trials: A Practical Guide

By Statistical Consultancy Team
August 14, 2026
Understand group sequential designs, stopping boundaries, alpha spending and when interim looks are useful in clinical trials.
Learn more

What is Audit Trail Review in Clinical Trials?

By Clinical Data Management Team
August 11, 2026
See how audit trail review supports clinical trial oversight through proportionate scope, clear ownership, contextual review, and documented findings.
Learn more

Subscribe to the Blog